Biosimilar Market Report

Global and Regional Biosimilar Market Details Research Report 2021-2026

  • POSTDATE：Jun 28, 2021
  • PAGES：202
  • REPORT CODE：GMM743063
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Biosimilar Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Biosimilar market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Biosimilar market.

    By Player:

    • Genor BioPharma

    • Biocon

    • BioXpress Therapeutics

    • Pfizer

    • Celltrion

    • Novartis

    • Dr Reddy’s Laboratories

    • BIOCAD

    • Allergan plc

    • Reliance Life Sciences

    • Intas Pharmaceuticals Limited

    • Coherus BioSciences

    • Boehringer Ingelheim

    By Type:

    • Human Growth Hormones

    • Monoclonal Antibodies

    • Insulin

    • Peptides

    • Erythropoietin

    • Others

    By End-User:

    • Oncology

    • Chronic and Autoimmune Diseases

    • Growth Hormone Deficiency

    • Infectious Diseases

    • Others

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Biosimilar Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Biosimilar Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Biosimilar Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Biosimilar Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Biosimilar Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Biosimilar Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Genor BioPharma

      • 3.1.1 Genor BioPharma - Company Business Overview

      • 3.1.2 Genor BioPharma - Company Financial Performance

      • 3.1.3 Genor BioPharma - Company Financial Performance of Biosimilar

      • 3.1.4 Biosimilar Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 Biocon

      • 3.2.1 Biocon - Company Business Overview

      • 3.2.2 Biocon - Company Financial Performance

      • 3.2.3 Biocon - Company Financial Performance of Biosimilar

      • 3.2.4 Biosimilar Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 BioXpress Therapeutics

      • 3.3.1 BioXpress Therapeutics - Company Business Overview

      • 3.3.2 BioXpress Therapeutics - Company Financial Performance

      • 3.3.3 BioXpress Therapeutics - Company Financial Performance of Biosimilar

      • 3.3.4 Biosimilar Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Pfizer

      • 3.4.1 Pfizer - Company Business Overview

      • 3.4.2 Pfizer - Company Financial Performance

      • 3.4.3 Pfizer - Company Financial Performance of Biosimilar

      • 3.4.4 Biosimilar Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 Celltrion

      • 3.5.1 Celltrion - Company Business Overview

      • 3.5.2 Celltrion - Company Financial Performance

      • 3.5.3 Celltrion - Company Financial Performance of Biosimilar

      • 3.5.4 Biosimilar Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 Novartis

      • 3.6.1 Novartis - Company Business Overview

      • 3.6.2 Novartis - Company Financial Performance

      • 3.6.3 Novartis - Company Financial Performance of Biosimilar

      • 3.6.4 Biosimilar Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 Dr Reddy’s Laboratories

      • 3.7.1 Dr Reddy’s Laboratories - Company Business Overview

      • 3.7.2 Dr Reddy’s Laboratories - Company Financial Performance

      • 3.7.3 Dr Reddy’s Laboratories - Company Financial Performance of Biosimilar

      • 3.7.4 Biosimilar Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 BIOCAD

      • 3.8.1 BIOCAD - Company Business Overview

      • 3.8.2 BIOCAD - Company Financial Performance

      • 3.8.3 BIOCAD - Company Financial Performance of Biosimilar

      • 3.8.4 Biosimilar Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Allergan plc

      • 3.9.1 Allergan plc - Company Business Overview

      • 3.9.2 Allergan plc - Company Financial Performance

      • 3.9.3 Allergan plc - Company Financial Performance of Biosimilar

      • 3.9.4 Biosimilar Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 Reliance Life Sciences

      • 3.10.1 Reliance Life Sciences - Company Business Overview

      • 3.10.2 Reliance Life Sciences - Company Financial Performance

      • 3.10.3 Reliance Life Sciences - Company Financial Performance of Biosimilar

      • 3.10.4 Biosimilar Product Benchmarking

      • 3.10.5 Strategic Initiatives

    • 3.11 Intas Pharmaceuticals Limited

      • 3.11.1 Intas Pharmaceuticals Limited - Company Business Overview

      • 3.11.2 Intas Pharmaceuticals Limited - Company Financial Performance

      • 3.11.3 Intas Pharmaceuticals Limited - Company Financial Performance of Biosimilar

      • 3.11.4 Biosimilar Product Benchmarking

      • 3.11.5 Strategic Initiatives

    • 3.12 Coherus BioSciences

      • 3.12.1 Coherus BioSciences - Company Business Overview

      • 3.12.2 Coherus BioSciences - Company Financial Performance

      • 3.12.3 Coherus BioSciences - Company Financial Performance of Biosimilar

      • 3.12.4 Biosimilar Product Benchmarking

      • 3.12.5 Strategic Initiatives

    • 3.13 Boehringer Ingelheim

      • 3.13.1 Boehringer Ingelheim - Company Business Overview

      • 3.13.2 Boehringer Ingelheim - Company Financial Performance

      • 3.13.3 Boehringer Ingelheim - Company Financial Performance of Biosimilar

      • 3.13.4 Biosimilar Product Benchmarking

      • 3.13.5 Strategic Initiatives

    4 Global Biosimilar Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Biosimilar Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Human Growth Hormones 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Monoclonal Antibodies 2016-2021

      • 4.2.3 Global Revenue and Growth Rate of Insulin 2016-2021

      • 4.2.4 Global Revenue and Growth Rate of Peptides 2016-2021

      • 4.2.5 Global Revenue and Growth Rate of Erythropoietin 2016-2021

      • 4.2.6 Global Revenue and Growth Rate of Others 2016-2021

    • 4.3 Global Biosimilar Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Human Growth Hormones 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Monoclonal Antibodies 2016-2021

      • 4.3.3 Global Sales and Growth Rate of Insulin 2016-2021

      • 4.3.4 Global Sales and Growth Rate of Peptides 2016-2021

      • 4.3.5 Global Sales and Growth Rate of Erythropoietin 2016-2021

      • 4.3.6 Global Sales and Growth Rate of Others 2016-2021

    • 4.4 Global Biosimilar Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Biosimilar Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Biosimilar Market Price By Type from 2016 to 2026

    5 Global Biosimilar Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Biosimilar

    • 5.2 Global Biosimilar Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Oncology 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Chronic and Autoimmune Diseases 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Growth Hormone Deficiency 2016-2021

      • 5.2.4 Global Revenue and Growth Rate of Infectious Diseases 2016-2021

      • 5.2.5 Global Revenue and Growth Rate of Others 2016-2021

    • 5.3 Global Biosimilar Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Oncology 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Chronic and Autoimmune Diseases 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Growth Hormone Deficiency 2016-2021

      • 5.3.4 Global Sales and Growth Rate of Infectious Diseases 2016-2021

      • 5.3.5 Global Sales and Growth Rate of Others 2016-2021

    • 5.4 Global Biosimilar Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Biosimilar Market Sales and Market Share by Application (Forecast)

    6 Global Biosimilar Market Segment Analysis (Geography Level)

    • 6.1 Global Biosimilar Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Biosimilar Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Biosimilar Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Biosimilar Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Biosimilar Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Biosimilar Market from 2016 to 2020

    7. North America Biosimilar Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Biosimilar Market Segment by Countries

      • 7.1.1 North America Biosimilar Market Revenue Segment by Countries

      • 7.1.2 North America Biosimilar Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Biosimilar Market Segment (Product Type Level)

    • 7.3 North America Biosimilar Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Biosimilar Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Biosimilar Market Segment by Countries

      • 8.1.1 Europe Biosimilar Market Revenue Segment by Countries

      • 8.1.2 Europe Biosimilar Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Biosimilar Market Segment (Product Type Level)

    • 8.3 Europe Biosimilar Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Biosimilar Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Biosimilar Market Segment by Countries

      • 9.1.1 Asia Biosimilar Market Revenue Segment by Countries

      • 9.1.2 Asia Biosimilar Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Biosimilar Market Segment (Product Type Level)

    • 9.3 Asia Biosimilar Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Biosimilar Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Biosimilar Market Segment by Countries

      • 10.1.1 South America Biosimilar Market Revenue Segment by Countries

      • 10.1.2 South America Biosimilar Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Biosimilar Market Segment (Product Type Level)

    • 10.3 South America Biosimilar Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Biosimilar Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Biosimilar Market Segment by Countries

      • 11.1.1 Middle East Biosimilar Market Revenue Segment by Countries

      • 11.1.2 Middle East Biosimilar Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Biosimilar Market Segment (Product Type Level)

    • 11.3 Middle East Biosimilar Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Biosimilar Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Biosimilar Market Segment by Countries

      • 12.1.1 Africa Biosimilar Market Revenue Segment by Countries

      • 12.1.2 Africa Biosimilar Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Biosimilar Market Segment (Product Type Level)

    • 12.3 Africa Biosimilar Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Biosimilar Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Biosimilar Market Segment by Countries

      • 13.1.1 Oceania Biosimilar Market Revenue Segment by Countries

      • 13.1.2 Oceania Biosimilar Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Biosimilar Market Segment (Product Type Level)

    • 13.3 Oceania Biosimilar Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Biosimilar Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Biosimilar

      • 14.2.2 Manufacturing Process Analysis of Biosimilar

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Biosimilar Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Biosimilar Industry Market Status, Pre-COVID-19

      • 15.5.3 Biosimilar Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Biosimilar Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Biosimilar Product Picture

    • Table Biosimilar Product Definition

    • Table Study Scope by Types

    • Figure Global Biosimilar Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Biosimilar Market Value by Application (2016 - 2026)

    • Figure Global Biosimilar Market Size and Growth Rate from 2016 to 2026

    • Table Global Biosimilar Production Capacity by Manufacturers (2016-2021)

    • Table Global Biosimilar Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Biosimilar Revenue by Manufacturers (2016-2021)

    • Table Global Biosimilar Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Biosimilar Plant Distribution and Sales Country

    • Table Genor BioPharma - Company Business Overview

    • Figure Genor BioPharma Total Revenue from 2018 to 2020

    • Table Genor BioPharma Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Genor BioPharma Sales and Growth Rate Analysis of Biosimilar

    • Figure Revenue and Market Share Analysis of Genor BioPharma

    • Table Biosimilar Product Benchmarking

    • Table Biocon - Company Business Overview

    • Figure Biocon Total Revenue from 2018 to 2020

    • Table Biocon Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Biocon Sales and Growth Rate Analysis of Biosimilar

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Biosimilar Product Benchmarking

    • Table BioXpress Therapeutics - Company Business Overview

    • Figure BioXpress Therapeutics Total Revenue from 2018 to 2020

    • Table BioXpress Therapeutics Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure BioXpress Therapeutics Sales and Growth Rate Analysis of Biosimilar

    • Figure Revenue and Market Share Analysis of BioXpress Therapeutics

    • Table Biosimilar Product Benchmarking

    • Table Pfizer - Company Business Overview

    • Figure Pfizer Total Revenue from 2018 to 2020

    • Table Pfizer Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Pfizer Sales and Growth Rate Analysis of Biosimilar

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Biosimilar Product Benchmarking

    • Table Celltrion - Company Business Overview

    • Figure Celltrion Total Revenue from 2018 to 2020

    • Table Celltrion Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Celltrion Sales and Growth Rate Analysis of Biosimilar

    • Figure Revenue and Market Share Analysis of Celltrion

    • Table Biosimilar Product Benchmarking

    • Table Novartis - Company Business Overview

    • Figure Novartis Total Revenue from 2018 to 2020

    • Table Novartis Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Novartis Sales and Growth Rate Analysis of Biosimilar

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Biosimilar Product Benchmarking

    • Table Dr Reddy’s Laboratories - Company Business Overview

    • Figure Dr Reddy’s Laboratories Total Revenue from 2018 to 2020

    • Table Dr Reddy’s Laboratories Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Dr Reddy’s Laboratories Sales and Growth Rate Analysis of Biosimilar

    • Figure Revenue and Market Share Analysis of Dr Reddy’s Laboratories

    • Table Biosimilar Product Benchmarking

    • Table BIOCAD - Company Business Overview

    • Figure BIOCAD Total Revenue from 2018 to 2020

    • Table BIOCAD Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure BIOCAD Sales and Growth Rate Analysis of Biosimilar

    • Figure Revenue and Market Share Analysis of BIOCAD

    • Table Biosimilar Product Benchmarking

    • Table Allergan plc - Company Business Overview

    • Figure Allergan plc Total Revenue from 2018 to 2020

    • Table Allergan plc Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Allergan plc Sales and Growth Rate Analysis of Biosimilar

    • Figure Revenue and Market Share Analysis of Allergan plc

    • Table Biosimilar Product Benchmarking

    • Table Reliance Life Sciences - Company Business Overview

    • Figure Reliance Life Sciences Total Revenue from 2018 to 2020

    • Table Reliance Life Sciences Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Reliance Life Sciences Sales and Growth Rate Analysis of Biosimilar

    • Figure Revenue and Market Share Analysis of Reliance Life Sciences

    • Table Biosimilar Product Benchmarking

    • Table Intas Pharmaceuticals Limited - Company Business Overview

    • Figure Intas Pharmaceuticals Limited Total Revenue from 2018 to 2020

    • Table Intas Pharmaceuticals Limited Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Intas Pharmaceuticals Limited Sales and Growth Rate Analysis of Biosimilar

    • Figure Revenue and Market Share Analysis of Intas Pharmaceuticals Limited

    • Table Biosimilar Product Benchmarking

    • Table Coherus BioSciences - Company Business Overview

    • Figure Coherus BioSciences Total Revenue from 2018 to 2020

    • Table Coherus BioSciences Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Coherus BioSciences Sales and Growth Rate Analysis of Biosimilar

    • Figure Revenue and Market Share Analysis of Coherus BioSciences

    • Table Biosimilar Product Benchmarking

    • Table Boehringer Ingelheim - Company Business Overview

    • Figure Boehringer Ingelheim Total Revenue from 2018 to 2020

    • Table Boehringer Ingelheim Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Boehringer Ingelheim Sales and Growth Rate Analysis of Biosimilar

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Biosimilar Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Biosimilar Market Revenue by Types (Historical)

    • Table Global Biosimilar Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Human Growth Hormones 2016-2021

    • Figure Global Revenue and Growth Rate of Monoclonal Antibodies 2016-2021

    • Figure Global Revenue and Growth Rate of Insulin 2016-2021

    • Figure Global Revenue and Growth Rate of Peptides 2016-2021

    • Figure Global Revenue and Growth Rate of Erythropoietin 2016-2021

    • Figure Global Revenue and Growth Rate of Others 2016-2021

    • Table Global Biosimilar Market Sales by Types (Historical)

    • Table Global Biosimilar Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Human Growth Hormones 2016-2021

    • Figure Global Sales and Growth Rate of Monoclonal Antibodies 2016-2021

    • Figure Global Sales and Growth Rate of Insulin 2016-2021

    • Figure Global Sales and Growth Rate of Peptides 2016-2021

    • Figure Global Sales and Growth Rate of Erythropoietin 2016-2021

    • Figure Global Sales and Growth Rate of Others 2016-2021

    • Table Global Biosimilar Market Revenue by Types (Forecast)

    • Table Global Biosimilar Market Revenue Market Share by Types (Forecast)

    • Table Global Biosimilar Market Sales by Types (Forecast)

    • Table Global Biosimilar Market Sales Market Share by Types (Forecast)

    • Figure Global Biosimilar Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Biosimilar

    • Table Global Biosimilar Market Revenue by Application (Historical)

    • Table Global Biosimilar Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Oncology 2016-2021

    • Figure Global Revenue and Growth Rate of Chronic and Autoimmune Diseases 2016-2021

    • Figure Global Revenue and Growth Rate of Growth Hormone Deficiency 2016-2021

    • Figure Global Revenue and Growth Rate of Infectious Diseases 2016-2021

    • Figure Global Revenue and Growth Rate of Others 2016-2021

    • Table Global Biosimilar Market Sales by Application (Historical)

    • Table Global Biosimilar Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Oncology 2016-2021

    • Figure Global Sales and Growth Rate of Chronic and Autoimmune Diseases 2016-2021

    • Figure Global Sales and Growth Rate of Growth Hormone Deficiency 2016-2021

    • Figure Global Sales and Growth Rate of Infectious Diseases 2016-2021

    • Figure Global Sales and Growth Rate of Others 2016-2021

    • Table Global Biosimilar Market Revenue by Application (Forecast)

    • Table Global Biosimilar Market Revenue Market Share by Application (Forecast)

    • Table Global Biosimilar Market Sales by Application (Forecast)

    • Table Global Biosimilar Market Sales Market Share by Application (Forecast)

    • Table Global Biosimilar Market Revenue by Geography (Historical)

    • Table Global Biosimilar Market Revenue Market Share by Geography (Historical)

    • Figure Global Biosimilar Revenue Market Share by Geography in 2020

    • Table Global Biosimilar Market Sales by Geography (Historical)

    • Table Global Biosimilar Market Sales Market Share by Geography (Historical)

    • Figure Global Biosimilar Sales Market Share by Geography in 2020

    • Table Global Biosimilar Market Revenue by Geography (Forecast)

    • Table Global Biosimilar Market Revenue Market Share by Geography (Forecast)

    • Table Global Biosimilar Market Sales by Geography (Forecast)

    • Table Global Biosimilar Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Biosimilar Revenue by Countries from 2016 to 2026

    • Table North America Biosimilar Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Biosimilar Revenue Market Share by Major Countries in 2020

    • Table North America Biosimilar Sales by Countries from 2016 to 2026

    • Table North America Biosimilar Sales Market Share by Countries from 2016 to 2026

    • Figure North America Biosimilar Sales Market Share by Major Countries in 2020

    • Figure USA Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure USA Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Table North America Biosimilar Sales by Types from 2016 to 2026

    • Table North America Biosimilar Sales Market Share by Types from 2016 to 2026

    • Table North America Biosimilar Value by Types from 2016 to 2026

    • Table North America Biosimilar Value Market Share by Types from 2016 to 2026

    • Table North America Biosimilar Sales by Application from 2016 to 2026

    • Table North America Biosimilar Sales Market Share by Application from 2016 to 2026

    • Table North America Biosimilar Value by Application from 2016 to 2026

    • Table North America Biosimilar Value Market Share by Application from 2016 to 2026

    • Table Europe Biosimilar Revenue by Countries from 2016 to 2026

    • Table Europe Biosimilar Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Biosimilar Revenue Market Share by Major Countries in 2020

    • Table Europe Biosimilar Sales by Countries from 2016 to 2026

    • Table Europe Biosimilar Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Biosimilar Sales Market Share by Major Countries in 2020

    • Figure Germany Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure France Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure France Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Biosimilar Sales by Types from 2016 to 2026

    • Table Europe Biosimilar Sales Market Share by Types from 2016 to 2026

    • Table Europe Biosimilar Value by Types from 2016 to 2026

    • Table Europe Biosimilar Value Market Share by Types from 2016 to 2026

    • Table Europe Biosimilar Sales by Application from 2016 to 2026

    • Table Europe Biosimilar Sales Market Share by Application from 2016 to 2026

    • Table Europe Biosimilar Value by Application from 2016 to 2026

    • Table Europe Biosimilar Value Market Share by Application from 2016 to 2026

    • Table Asia Biosimilar Revenue by Countries from 2016 to 2026

    • Table Asia Biosimilar Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Biosimilar Revenue Market Share by Major Countries in 2020

    • Table Asia Biosimilar Sales by Countries from 2016 to 2026

    • Table Asia Biosimilar Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Biosimilar Sales Market Share by Major Countries in 2020

    • Figure China Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure China Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure India Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure India Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Biosimilar Sales by Types from 2016 to 2026

    • Table Asia Biosimilar Sales Market Share by Types from 2016 to 2026

    • Table Asia Biosimilar Value by Types from 2016 to 2026

    • Table Asia Biosimilar Value Market Share by Types from 2016 to 2026

    • Table Asia Biosimilar Sales by Application from 2016 to 2026

    • Table Asia Biosimilar Sales Market Share by Application from 2016 to 2026

    • Table Asia Biosimilar Value by Application from 2016 to 2026

    • Table Asia Biosimilar Value Market Share by Application from 2016 to 2026

    • Table South America Biosimilar Revenue by Countries from 2016 to 2026

    • Table South America Biosimilar Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Biosimilar Revenue Market Share by Major Countries in 2020

    • Table South America Biosimilar Sales by Countries from 2016 to 2026

    • Table South America Biosimilar Sales Market Share by Countries from 2016 to 2026

    • Figure South America Biosimilar Sales Market Share by Major Countries in 2020

    • Figure Brazil Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Table South America Biosimilar Sales by Types from 2016 to 2026

    • Table South America Biosimilar Sales Market Share by Types from 2016 to 2026

    • Table South America Biosimilar Value by Types from 2016 to 2026

    • Table South America Biosimilar Value Market Share by Types from 2016 to 2026

    • Table South America Biosimilar Sales by Application from 2016 to 2026

    • Table South America Biosimilar Sales Market Share by Application from 2016 to 2026

    • Table South America Biosimilar Value by Application from 2016 to 2026

    • Table South America Biosimilar Value Market Share by Application from 2016 to 2026

    • Table Middle East Biosimilar Revenue by Countries from 2016 to 2026

    • Table Middle East Biosimilar Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Biosimilar Revenue Market Share by Major Countries in 2020

    • Table Middle East Biosimilar Sales by Countries from 2016 to 2026

    • Table Middle East Biosimilar Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Biosimilar Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Biosimilar Sales by Types from 2016 to 2026

    • Table Middle East Biosimilar Sales Market Share by Types from 2016 to 2026

    • Table Middle East Biosimilar Value by Types from 2016 to 2026

    • Table Middle East Biosimilar Value Market Share by Types from 2016 to 2026

    • Table Middle East Biosimilar Sales by Application from 2016 to 2026

    • Table Middle East Biosimilar Sales Market Share by Application from 2016 to 2026

    • Table Middle East Biosimilar Value by Application from 2016 to 2026

    • Table Middle East Biosimilar Value Market Share by Application from 2016 to 2026

    • Table Africa Biosimilar Revenue by Countries from 2016 to 2026

    • Table Africa Biosimilar Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Biosimilar Revenue Market Share by Major Countries in 2020

    • Table Africa Biosimilar Sales by Countries from 2016 to 2026

    • Table Africa Biosimilar Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Biosimilar Sales Market Share by Major Countries in 2020

    • Figure Nigeria Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Biosimilar Sales by Types from 2016 to 2026

    • Table Africa Biosimilar Sales Market Share by Types from 2016 to 2026

    • Table Africa Biosimilar Value by Types from 2016 to 2026

    • Table Africa Biosimilar Value Market Share by Types from 2016 to 2026

    • Table Africa Biosimilar Sales by Application from 2016 to 2026

    • Table Africa Biosimilar Sales Market Share by Application from 2016 to 2026

    • Table Africa Biosimilar Value by Application from 2016 to 2026

    • Table Africa Biosimilar Value Market Share by Application from 2016 to 2026

    • Table Oceania Biosimilar Revenue by Countries from 2016 to 2026

    • Table Oceania Biosimilar Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Biosimilar Revenue Market Share by Major Countries in 2020

    • Table Oceania Biosimilar Sales by Countries from 2016 to 2026

    • Table Oceania Biosimilar Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Biosimilar Sales Market Share by Major Countries in 2020

    • Figure Australia Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Biosimilar Market Value and Growth Rate from 2016 to 2026

    • Figure Others Biosimilar Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Biosimilar Sales by Types from 2016 to 2026

    • Table Oceania Biosimilar Sales Market Share by Types from 2016 to 2026

    • Table Oceania Biosimilar Value by Types from 2016 to 2026

    • Table Oceania Biosimilar Value Market Share by Types from 2016 to 2026

    • Table Oceania Biosimilar Sales by Application from 2016 to 2026

    • Table Oceania Biosimilar Sales Market Share by Application from 2016 to 2026

    • Table Oceania Biosimilar Value by Application from 2016 to 2026

    • Table Oceania Biosimilar Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Biosimilar

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Biosimilar with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US